Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FOXA1 overexpression effect on prostate cancer cell line
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Effect of FOXA1 overexpression in prostate cancer
PubMed Full text in PMC Similar studies Analyze with GEO2R
Cooperativity and Equilibrium with FOXA1 Define Androgen Receptor Transcriptional Program
Cooperativity and Equilibrium with FOXA1 Define Androgen Receptor Transcriptional Program [array]
FoxA1 inhibits androgen receptor expression and suppresses prostate cancer metastasis [DU145, ChIP-seq]
PubMed Full text in PMC Similar studies SRA Run Selector
FoxA1 inhibits androgen receptor expression and suppresses prostate cancer metastasis [LNCaP, ChIP-seq]
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines
PubMed Full text in PMC Similar studies
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq]
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [ChIP-seq]
Whole genome expression analysis of clinical bone metastasis samples
Selective Targeting of PARP2 Inhibits Androgen Receptor Signaling and Prostate Cancer Growth Through Disruption of FOXA1 Function
Genome-wide occupation of AR, FOXA1, and H3K27AC in LNCaP cells treated with selective PARP2 inhibitor UPF-1069
Gene expression profilings for prostate cancer cells after inhibition of PARP1 or PARP2 using pharmaceutical or siRNA-based approaches
Effect of p53 knowkdown on genome-wide map of AR-DNA binding
Identification and characterization of androgen receptor splice variants preferred bindings that drive prostate cancer progression
Identification and characterization of androgen receptor splice variants preferred bindings that drive prostate cancer progression [ChIP-seq]
Identification and characterization of androgen receptor splice variants preferred bindings that drive prostate cancer progression [RNA-seq]
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development
Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells
Total RNA-Seq in control and TRAF4-overexpressing LNCaP cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on